Evaluating the Role of Step Counts in Predicting Readmission and Mortality
NCT: NCT06687330 · COMPLETED
Brief Summary
This study investigates the relationship between physical activity, heart rate, and sleep quality with recurrent hospitalizations among discharged oncology patients. Following discharge, patients will wear Huawei smartwatches to enable daily tracking of step count, heart rate, and sleep duration through a connected smartphone app. Patients will also complete the FACT Quality of Life Survey and the Pittsburgh Sleep Quality Index during follow-up visits. The smartwatch monitoring will occur during the first 30 days post-discharge, while overall patient follow-up will extend up to 90 days. This study aims to determine if lower levels of home mobility, as indicated by step count and other activity metrics, correlate with an increased risk of hospital readmission within the 30-90 day period.
Frequently Asked Questions
What is Evaluating the Role of Step Counts in Predicting Readmission and Mortality?
Evaluating the Role of Step Counts in Predicting Readmission and Mortality is a clinical trial registered under NCT06687330. Current status: COMPLETED.
What is the status of NCT06687330?
The current status of NCT06687330 (Evaluating the Role of Step Counts in Predicting Readmission and Mortality) is: COMPLETED.
When did Evaluating the Role of Step Counts in Predicting Readmission and Mortality start?
Evaluating the Role of Step Counts in Predicting Readmission and Mortality started on 2024-11-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.